Cardiac Positron Emission Tomography
Springer-Verlag New York Inc.
978-1-4612-8524-3 (ISBN)
I. Methodology.- 1. Trends in Instrumentation.- 2. Attenuation Correction: Practical Considerations.- 3. Radiopharmaceuticals.- 4. Utility and Limitations of [18F]2-Deoxy-2-Fluoro-D-Glucose for the Assessment of Flux Through Metabolic Pathways in Heart Muscle: A Critical Appraisal.- 5. Quantitative Evaluation of Myocardial Perfusion.- II. Myocardial Perfusion Imaging.- 6. Assessment of Myocardial Perfusion with 13N-Ammonia or 82Rb.- 7. Assessment of Myocardial Perfusion with 15O-Water.- 8. 62Cu-PTSM: A Generator-Based Radiopharmaceutical for Myocardial Perfusion Imaging.- 9. Comparison of Cost-Effectiveness of Myocardial Perfusion Imaging Versus Other Approaches: Predictions by a Model.- III. Assessment of Tissue Viability.- 10. Assessment of Blood Flow and Substrate Metabolism in the Myocardium of the Normal Human Heart.- 11. Comparison of SPECT and PET for Assessment of Tissue Viability.- 12. 11C-Acetate in the Study of Ischemic Heart Disease.- 13. Assessment of Myocardial Viability using 15O-Water.- 14. Myocardial 82Rb Kinetics Identify Cell Membrane Integrity and Tissue Viability.- 15. Imaging Hypoxic Myocardium.- IV. Other Applications.- 16. Quantification of Myocardial Oxygen Consumption using 11C-Acetate.- 17. Applications in Nonischemic Heart Disease and Heart Failure.- 18. Use of PET Radiopharmaceuticals to Probe Cardiac Receptors.- V. Appendix.- 19. Clinical PET Protocols.
Reihe/Serie | Developments in Cardiovascular Medicine ; 165 |
---|---|
Zusatzinfo | XXII, 366 p. |
Verlagsort | New York, NY |
Sprache | englisch |
Maße | 155 x 235 mm |
Themenwelt | Medizinische Fachgebiete ► Innere Medizin ► Kardiologie / Angiologie |
ISBN-10 | 1-4612-8524-0 / 1461285240 |
ISBN-13 | 978-1-4612-8524-3 / 9781461285243 |
Zustand | Neuware |
Informationen gemäß Produktsicherheitsverordnung (GPSR) | |
Haben Sie eine Frage zum Produkt? |
aus dem Bereich